The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane
Open accessAbstract
Despite being engineered to avoid renal clearance, many cationic polymer (polycation)-based siRNA nanoparticles that are used for systemic delivery are rapidly eliminated from the circulation. Here, we show that a component of the renal filtration barrier—the glomerular basement membrane (GBM)—can disassemble cationic cyclodextrin-containing polymer (CDP)-based siRNA nanoparticles and, thereby, facilitate their rapid elimination from circulation. Using confocal and electron microscopies, positron emission tomography, and compartment modeling, we demonstrate that siRNA nanoparticles, but not free siRNA, accumulate and disassemble in the GBM. We also confirm that the siRNA nanoparticles do not disassemble in blood plasma in vitro and in vivo. This clearance mechanism may affect any nanoparticles that assemble primarily by electrostatic interactions between cationic delivery components and anionic nucleic acids (or other therapeutic entities).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476 · cited 1×
“The rapid clearance of these siRNA nanoparticles is puzzling because they are engineered to be above the size cutoff for single-pass clearance via renal filtration (13).”
BackgroundNanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233 · cited 2×
“In understanding the mechanism behind the rapid clearance of this type of cancer therapeutic, we can efficiently seek ways to increase their circulation time and, thus, enhance their anticancer efficacy (3).”
BackgroundSelf-citationEvidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Self-citationThe promises and pitfalls of RNA-interference-based therapeutics
Castanotto, D., & Rossi, J. J. (2009) · Nature · doi:10.1038/nature07758 · Cited by 1,221
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 803
Self-citationPresence of heparan sulfate in the glomerular basement membrane
Kanwar, Y. S., & Farquhar, M. G. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1303 · Cited by 562
Kanwar, Y. S., & Farquhar, M. G. (1979) · The Journal of cell biology · doi:10.1083/jcb.81.1.137 · Cited by 553
A New Method for Large Scale Isolation of Kidney Glomeruli from Mice
Takemoto, M., Asker, N., Gerhardt, H., Lundkvist, A., Johansson, B. R., Saito, Y., & Betsholtz, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64239-3 · Cited by 516
Targeting kidney mesangium by nanoparticles of defined size
Choi, C. H. J., Zuckerman, J. E., Webster, P., & Davis, M. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103573108 · Cited by 502
Self-citationHeidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701458104 · Cited by 382
Self-citationsiRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney Injury
Molitoris, B. A., Dagher, P. C., Sandoval, R. M., Campos, S. B., Ashush, H., Fridman, E., Brafman, A., Faerman, A., Atkinson, S. J., Thompson, J. D., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111204 · Cited by 337
Gao, S., Dagnaes-Hansen, F., Nielsen, E. J. B., Wengel, J., Besenbacher, F., Howard, K. A., & Kjems, J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.91 · Cited by 286
Physicochemical and Biological Characterization of Targeted, Nucleic Acid-Containing Nanoparticles
Bartlett, D. W., & Davis, M. E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603539 · Cited by 283
Self-citationExtracellular Barriers to in Vivo PEI and PEGylated PEI Polyplex-Mediated Gene Delivery to the Liver
Burke, R. S., & Pun, S. H. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700388u · Cited by 221
Malek, A., Merkel, O., Fink, L., Czubayko, F., Kissel, T., & Aigner, A. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.01.014 · Cited by 185
Merkel, O. M., Librizzi, D., Pfestroff, A., Schurrat, T., Buyens, K., Sanders, N. N., De Smedt, S. C., Béhé, M., & Kissel, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.016 · Cited by 183
Bartlett, D. W., & Davis, M. E. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21285 · Cited by 153
Self-citationDevelopment of universal antidotes to control aptamer activity
Oney, S., Lam, R. T. S., Bompiani, K. M., Blake, C. M., Quick, G., Heidel, J. D., Liu, J. Y.-C., Mack, B. C., Davis, M. E., Leong, K. W., et al. (2009) · Nature Medicine · doi:10.1038/nm.1990 · Cited by 126
Self-citationPodocytes Are Firmly Attached to Glomerular Basement Membrane in Kidneys with Heavy Proteinuria
Lahdenkari, A.-T., Lounatmaa, K., Patrakka, J., Holmberg, C., Wartiovaara, J., Diaeresis], M. K., Koskimies, O., & Jalanko, H. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000139478.03463.d9 · Cited by 121
Mishra, S., Heidel, J. D., Webster, P. C., & Davis, M. E. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.018 · Cited by 115
Self-citationMerkel, O. M., Mintzer, M. A., Librizzi, D., Samsonova, O. V., Dicke, T., Sproat, B. S., Garn, H., Barth, P. J., Simanek, E. E., & Kissel, T. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100101s · Cited by 114
DEWOLF, H., Snel, C. J., Verbaan, F. J., Schiffelers, R. M., Hennink, W. E., & Storm, G. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.029 · Cited by 112
Foglieni, C., Bragonzi, A., Cortese, M., Cantú, L., Boletta, A., Chiossone, I., Soria, M. R., & Monaco, L. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301092 · Cited by 22
Cited by
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990
Self-citationDelivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
Targeted drug delivery strategies for precision medicines
Manzari, M. T., Shamay, Y., Kiguchi, H., Rosen, N., Scaltriti, M., & Heller, D. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-020-00269-6 · Cited by 1,183
Metadata
- Authors
- Zuckerman, J. E., Choi, C. H. J., Han, H., & Davis, M. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2012-02-06
- Volume
- 109
- Issue
- 8
- Pages
- 3137-3142
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2067302150
- Cited by
- 372
- References
- 24
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.